Abbott Laboratories (ABT)
117.26
+1.33
(+1.15%)
USD |
NYSE |
Nov 21, 16:00
116.86
-0.40
(-0.34%)
Pre-Market: 05:14
Abbott Laboratories Shareholders Equity (Quarterly): 39.80B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 39.80B |
June 30, 2024 | 39.32B |
March 31, 2024 | 38.81B |
December 31, 2023 | 38.60B |
September 30, 2023 | 37.48B |
June 30, 2023 | 37.17B |
March 31, 2023 | 37.01B |
December 31, 2022 | 36.69B |
September 30, 2022 | 35.68B |
June 30, 2022 | 36.49B |
March 31, 2022 | 35.40B |
December 31, 2021 | 35.80B |
September 30, 2021 | 34.42B |
June 30, 2021 | 33.80B |
March 31, 2021 | 33.56B |
December 31, 2020 | 32.78B |
September 30, 2020 | 31.39B |
June 30, 2020 | 30.58B |
March 31, 2020 | 30.22B |
December 31, 2019 | 31.09B |
September 30, 2019 | 31.82B |
June 30, 2019 | 31.69B |
March 31, 2019 | 30.92B |
December 31, 2018 | 30.52B |
September 30, 2018 | 30.70B |
Date | Value |
---|---|
June 30, 2018 | 30.58B |
March 31, 2018 | 31.40B |
December 31, 2017 | 30.90B |
September 30, 2017 | 32.03B |
June 30, 2017 | 31.60B |
March 31, 2017 | 31.36B |
December 31, 2016 | 20.54B |
September 30, 2016 | 20.78B |
June 30, 2016 | 20.68B |
March 31, 2016 | 20.72B |
December 31, 2015 | 21.21B |
September 30, 2015 | 21.11B |
June 30, 2015 | 23.01B |
March 31, 2015 | 21.87B |
December 31, 2014 | 21.53B |
September 30, 2014 | 22.89B |
June 30, 2014 | 23.60B |
March 31, 2014 | 23.39B |
December 31, 2013 | 25.17B |
September 30, 2013 | 23.70B |
June 30, 2013 | 22.34B |
March 31, 2013 | 22.59B |
December 31, 2012 | 26.72B |
September 30, 2012 | 27.01B |
June 30, 2012 | 24.49B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
30.22B
Minimum
Mar 2020
39.80B
Maximum
Sep 2024
35.30B
Average
35.74B
Median
Shareholders Equity (Quarterly) Benchmarks
Boston Scientific Corp | 20.71B |
Becton Dickinson & Co | 25.91B |
ResMed Inc | 5.195B |
Globus Medical Inc | 4.069B |
Insulet Corp | 1.118B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 74.36B |
Total Liabilities (Quarterly) | 34.33B |
Debt to Equity Ratio | 0.3764 |
Current Ratio | 1.597 |
Net Debt Paydown Yield | 0.19% |